Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. • Bellmunt J, Théodore C, Demkov T, et al. Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract. J Clin Oncol. 2009;27(27):4454. The only phase 3 trial in a second-line setting that evaluated vinflunine is reported in this paper.
2. Galsky MD, Mironov S, Iasonos A, et al. Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma. Invest New Drugs. 2007;25:265.
3. Sweeney CJ, Roth BJ, Kabbinavar FF, et al. Phase II study of pemetrexed for second line treatment of transitional cell cancer of the urothelium. J Clin Oncol. 2006;24:3451.
4. Von der Maase H, Lehmann J, Gravis G, et al. A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium. Ann Oncol. 2006;17:1533.
5. Sridhar SS, Canil CM, Mukherjee SD et al. Results of a phase II study of single agent nab-paclitaxel in platinum refractory second line metastatic urothelial carcinoma. J Clin Oncol. 2011;suppl 7, abstract 241.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献